हिंदी में पढ़ें
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
MF Returns Calculator
In chat with Anil Singhvi, analyst Vikas Sethi recommends Hikal, Biocon as top buys for big gains
Sun, Apr 18, 2021
Analyst Vikas Sethi’s first stock was Hikal, which he called as an excellent stock. This stock was trading around Rs 178 at the time of recommendation. This is into the business of manufacturing Pharma APIs. It is also in crop protection and speciality chemicals. It has five manufacturing plants in Maharashtra and Karnataka. The fundamentals of this company are quite strong he said
Stocks to buy with Anil Singhvi: Here are Vikas Sethi’s top two picks today for good returns
Fri, Apr 16, 2021
Zee Business Managing Editor Anil Singhvi, in the latest episode of ‘Sadabahaar Sethi Saab’ show, spoke to market analyst Vikas Sethi and asked him to reveal his top picks that can generate good returns for investors. Sethi gave two calls today—one from the cash market and another from F&O space
Biocon share price today: HSBC revises target price to Rs 480 from Rs 455 for Biocon
Tue, Mar 23, 2021
HSBC remains positive on Biocon’s long term prospects for biosimilars and believes that improved execution of launches in the US and a renewed focus for MoW markets should help it to better pick-up biosimilars sales. Market opportunities remain abundant in DM (28 products in the pipeline with cumulative brand sales of USD 80 bn).
Auto Stocks, Fortis Healthcare, Metal Stocks, Biocon to SRF - here are top Buzzing Stocks today
Fri, Jan 22, 2021
The domestic benchmarks have extended their losses and fell over half a per cent in noon deals on Friday, January 22, 2021. The fall was dragged mainly by heavyweight Reliance Industries and private banks.
Biocon Biologics appoints Prof Peter Piot as independent director
Fri, Jan 22, 2021
Biocon Biologics, a subsidiary of Biocon, on Thursday said it has appointed Professor Peter Piot as an independent director to its board for three years.
Aurobindo Pharma, Biocon, Dr Reddy’s Lab and Divi’s Laboratories: Resilient demand points to another good year for Pharma Sector says HSBC
Thu, Jan 21, 2021
After four difficult years, the India pharma sector rallied in 2020, and HSBC expects the benign operating environment to lead to another good year. HSBC revised their estimates and target prices, and rolled forward our valuations to December 2022e from September 2022e. HSBC also preview Q3 FY21e results, where they expect the recovery to continue for most of the companies that HSBC covers.
Jefferies on Pharma London Conference Highlights: Mylan, Biocon, Moderna, Suboxone, Alembic Pharma and more - all you need to know in brief
Thu, Nov 19, 2020
Moderna needs 151 cases for final analysis. With the final analysis, Moderna will file EUA in the US and bring other regulators including UK and EU up to speed. In the US, FDA will go through an adcom before granting EUA. Moderna is adding manufacturing lines to ramp up capacity and plans to produce 500 mn-1 bn doses a year, with raw material availability being the swing factor. Moderna has been talking to governments around the world since May.
Biocon arm to give Rs 65 crore to build metro station in Bengaluru
Fri, Oct 09, 2020
Biocon Foundation is giving Rs 65 crore to the state-run Bangalore Metro Rail Corporation Ltd (BMRCL) for constructing the Hebbagodi metro station in the city`s southern suburb as part of its corporate social responsibility, the firm said on Thursday.
Stocks in Focus on July 24: Biocon, Yes Bank, Axis Bank to Max Financial; here are expected newsmakers of the day
Fri, Jul 24, 2020
Stocks in Focus on July 24: Biocon, Yes Bank, Axis Bank, Max Financial, etc. are expected newsmakers throughout the intraday trade session.
Itolizumab is a breakthrough drug; Its Phase-IV trail will be conducted soon: Kiran Mazumdar Shaw, Biocon
Thu, Jul 16, 2020
Biocon's Executive Chairperson Kiran Mazumdar Shaw talks about its Itolizumab, drug that has been approved by DGCI for restricted use on COVID-19 patients; response towards the drug; its current production capacity and plans to ramp-up the production among other things during an exclusive interview with Zee Business Executive Swati Khandelwal
Stock Market Today: Sensex, Nifty trade tepid on weak global cues; Pfizer, Biocon shares gain
Tue, Jul 14, 2020
Stock Market Today: The BSE Sensex opened 272 points lower from the Monday close and hit 36,421 levels while the NSE Nifty was down 70 points to 10,732 mark.
Biocon drug receives DCGI nod for use in moderate to severe COVID-19 patients
Sat, Jul 11, 2020
Biocon on Saturday announced that its "breakthrough drug," Itolizumab has received Drugs Controller General of India's (DCGI) approval for its use in moderate to severe COVID-19 patients.
Stocks in Focus on April 29: Axis Bank, Biocon, HUL to Power stocks; here are expected 5 Newsmakers of the Day
Wed, Apr 29, 2020
Stocks in Focus on April 29: Axis Bank, Biocon, HUL, Gabriel India and Power stocks are the expected five newsmakers throughout the intraday trade session today.
We have to focus on the seriousness of COVID-19 in India: Kiran Mazumdar Shaw
Thu, Apr 02, 2020
The virus is spreading and we will have to pay attention to its seriousness, i.e. how many critical cases do we have, how many people do we have in ICU and ventilators because it will allow us to know about the kind of pressure on the hospitals.
Stocks in Focus on March 12: SBI, Yes Bank to IndiGo; here are expected 5 Newsmakers of the Day
Thu, Mar 12, 2020
Stocks in Focus on March 12: SBI, Yes Bank, IndiGo, L&T and Biocon are the expected 5 newsmakers throughout the intraday trade.
Biocon's Kiran Mazumdar-Shaw awarded 'Order of Australia'
Sun, Jan 19, 2020
Biopharmaceutical company Biocon on Saturday said that its Chairperson and Managing Director Kiran Mazumdar-Shaw has been awarded the -- 'Order of Australia' -- Australia's highest civilian honour.
Stocks in Focus on October 10: TCS, Tata Steel to REL; here are the 5 Newsmakers of the Day
Fri, Oct 11, 2019
Tata Consultancy Services or TCS, Tata Steel, Biocon, Religare Enterprises and NCC are the five stocks that are expected to remain newsmakers throughout the day.
Stocks in Focus on September 3: Biocon, KNR Construction to JK Tyre; here are the 5 Newsmakers of the Day
Tue, Sep 03, 2019
Certain stocks came in news after the market was closed on Friday and can have an impact on the market when it reopens today after three days break.
Sensex nudge down, Nifty retains 11K levels; Vodafone Idea, Reliance Capital, Biocon stocks bleed
Tue, Aug 20, 2019
The BSE Sensex nudged 74 points down and closed at 37,328 levels while the 50-stock Nifty lost 36 points but retained the psychological 11,000 levels after closing at 11,017 levels.
Biocon net zooms 86% in first quarter
Fri, Jul 26, 2019
"Robust performance by biologics and small molecules business segments fuelled the growth in the first quarter. Investments in biosimilars are delivering expected results," said Biocon Chairperson Kiran Mazumdar-Shaw in a statement later here.